Page 27 - Astrazeneca

AstraZeneca reaches out to rival Gilead with a merger proposal: Report

The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up

Serum Institute risks making Covid vaccine before trial at new $100 mn unit

AstraZeneca deal with SII is for supply of a billion doses, with a commitment to provide 400 mn before 2020-end. If all goes well, India could have its first set of Covid-19 vaccines by end of year

US secures 300 million doses of potential AstraZeneca Covid-19 vaccine

Vaccines are seen by world leaders as the only real way to restart their stalled economies.

First copies of Gilead coronavirus drug to start selling in Bangladesh

The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals

Britain's AstraZeneca to make bn Covid-19 vaccine doses if tests succeed

Drugmaker says it had signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing with Oxford University.

AstraZeneca says data from Covid-19 vaccine's phase-1 trials to be out soon

Once the late stage trials begin, the company simultaneously will start working on the global manufacturing capabilities.

AstraZeneca plans to test new cancer medicine in coronavirus battle

The treatment for lymphoma may lessen the severity of respiratory distress by reducing the inflammation caused by the new coronavirus

Diabetes will be one of our key focus areas: AstraZeneca's Gagan Singh Bedi

British drugmaker AstraZeneca, which has committed to invest $90 million in India over five years, has set up Integrated Cardio Metabolic Centre in Kerala for holistic treatment of diabetes

Strong demand for cancer drugs drives AstraZeneca to sales growth in Q3CY18

It is the first quarter of sustainable product sales growth since 2014 and shares in the group, which staved off a takeover bid from Pfizer four years ago, rose 2% by 0920 GMT on Thursday

AstraZeneca's drug extending survival rate in lung cancer patients

Using Imfinzi in stage III lung cancer, where cancer has only spread locally, opens up a multibillion-dollar sales opportunity

AstraZeneca shares plunge 16% as lung cancer study fails

The two injectable immunotherapy drugs failed to help patients in an advanced lung cancer trial

Initiate suitable prosecution steps against AstraZeneca management, pleads FMRI

The company recently terminated 50 employees

AstraZeneca medical representatives threaten strike

Staff go on mass leave to protest layoffs

AstraZeneca saves $400 mn through in-house IT spending

The company's Chennai facility will have two-thirds of its total number of IT employees by year end